Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2008 2
2010 1
2011 4
2012 10
2013 12
2014 8
2015 5
2016 4
2017 5
2018 10
2019 10
2020 3
2021 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Results by year

Filters applied: . Clear all
Page 1
Dostarlimab for Primary Advanced or Recurrent Endometrial Cancer.
Mirza MR, Chase DM, Slomovitz BM, dePont Christensen R, Novák Z, Black D, Gilbert L, Sharma S, Valabrega G, Landrum LM, Hanker LC, Stuckey A, Boere I, Gold MA, Auranen A, Pothuri B, Cibula D, McCourt C, Raspagliesi F, Shahin MS, Gill SE, Monk BJ, Buscema J, Herzog TJ, Copeland LJ, Tian M, He Z, Stevens S, Zografos E, Coleman RL, Powell MA; RUBY Investigators. Mirza MR, et al. Among authors: depont christensen r. N Engl J Med. 2023 Jun 8;388(23):2145-2158. doi: 10.1056/NEJMoa2216334. Epub 2023 Mar 27. N Engl J Med. 2023. PMID: 36972026 Clinical Trial.
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.
González-Martín A, Pothuri B, Vergote I, DePont Christensen R, Graybill W, Mirza MR, McCormick C, Lorusso D, Hoskins P, Freyer G, Baumann K, Jardon K, Redondo A, Moore RG, Vulsteke C, O'Cearbhaill RE, Lund B, Backes F, Barretina-Ginesta P, Haggerty AF, Rubio-Pérez MJ, Shahin MS, Mangili G, Bradley WH, Bruchim I, Sun K, Malinowska IA, Li Y, Gupta D, Monk BJ; PRIMA/ENGOT-OV26/GOG-3012 Investigators. González-Martín A, et al. Among authors: depont christensen r. N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28. N Engl J Med. 2019. PMID: 31562799 Clinical Trial.
Niraparib plus bevacizumab versus niraparib alone for platinum-sensitive recurrent ovarian cancer (NSGO-AVANOVA2/ENGOT-ov24): a randomised, phase 2, superiority trial.
Mirza MR, Åvall Lundqvist E, Birrer MJ, dePont Christensen R, Nyvang GB, Malander S, Anttila M, Werner TL, Lund B, Lindahl G, Hietanen S, Peen U, Dimoula M, Roed H, Ør Knudsen A, Staff S, Krog Vistisen A, Bjørge L, Mäenpää JU; AVANOVA investigators. Mirza MR, et al. Among authors: depont christensen r. Lancet Oncol. 2019 Oct;20(10):1409-1419. doi: 10.1016/S1470-2045(19)30515-7. Epub 2019 Aug 29. Lancet Oncol. 2019. PMID: 31474354 Clinical Trial.
Religious Values in Clinical Practice are Here to Stay.
Kørup AK, Søndergaard J, Christensen RD, Nielsen CT, Lucchetti G, Ramakrishnan P, Baumann K, Lee E, Frick E, Büssing A, Alyousefi NA, Karimah A, Schouten E, Schulze A, Wermuth I, Hvidt NC. Kørup AK, et al. Among authors: christensen rd. J Relig Health. 2020 Feb;59(1):188-194. doi: 10.1007/s10943-018-0715-y. J Relig Health. 2020. PMID: 30328542 Free PMC article.
Medical engagement and organizational characteristics in general practice.
Ahnfeldt-Mollerup P, dePont Christensen R, Halling A, Kristensen T, Lykkegaard J, Nexøe J, Barwell F, Spurgeon P, Søndergaard J. Ahnfeldt-Mollerup P, et al. Among authors: depont christensen r. Fam Pract. 2016 Feb;33(1):69-74. doi: 10.1093/fampra/cmv085. Epub 2015 Oct 26. Fam Pract. 2016. PMID: 26502810
Reasons for diagnostic delay in gynecological malignancies.
Vandborg MP, Christensen RD, Kragstrup J, Edwards K, Vedsted P, Hansen DG, Mogensen O. Vandborg MP, et al. Among authors: christensen rd. Int J Gynecol Cancer. 2011 Aug;21(6):967-74. doi: 10.1097/IGC.0b013e31821d2770. Int J Gynecol Cancer. 2011. PMID: 21792008
70 results